Security key
00847X104
AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO)
CUSIP: 00847X104
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, Par Value $0.001 per share
- Shares outstanding
- 59,431,072
- Total 13F shares
- 59,832,436
- Share change
- +1,686,750
- Total reported value
- $1,966,429,716
- Put/Call ratio
- 121%
- Price per share
- $32.86
- Number of holders
- 221
- Value change
- +$37,958,970
- Number of buys
- 116
- Number of sells
- 94
Report period
Q4 2024
Institutions
221
Top holders
10
AGIO full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
AGIOS PHARMACEUTICALS, INC. SEC filings
AGIOS PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00847X104
Recent filing periods:
Top shareholders of AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
9.5%
|
5,660,866
|
$251,512,276 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.3%
|
5,545,982
|
$246,407,980 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
8.4%
|
5,021,767
|
$223,117,106 | — | 30 Sep 2024 | |
| Bellevue Group AG |
13F
|
Company |
6.3%
|
3,735,915
|
$165,986,703 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4.8%
|
2,832,512
|
$125,849,000 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.9%
|
2,331,433
|
$103,585,568 | — | 30 Sep 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
3.7%
|
2,207,070
|
$98,060,120 | — | 30 Sep 2024 | |
| Erste Asset Management GmbH |
13F
|
Company |
3.7%
|
2,184,900
|
$97,198,889 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.9%
|
1,712,990
|
$76,108,145 | — | 30 Sep 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
2.8%
|
1,690,801
|
$75,122,000 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.6%
|
1,562,183
|
$69,411,643 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
1,357,531
|
$60,326,377 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
2.1%
|
1,263,285
|
$56,127,753 | — | 30 Sep 2024 | |
| BVF INC/IL |
13F
|
Company |
2%
|
1,190,107
|
$52,876,454 | — | 30 Sep 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.8%
|
1,044,154
|
$46,391,762 | — | 30 Sep 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1.7%
|
1,002,036
|
$44,520,459 | — | 30 Sep 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
1.5%
|
907,044
|
$40,300,000 | — | 30 Sep 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.5%
|
882,731
|
$39,219,738 | — | 30 Sep 2024 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1.4%
|
855,328
|
$38,002,222 | — | 30 Sep 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
1.3%
|
760,000
|
$33,766,800 | — | 30 Sep 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.2%
|
699,389
|
$31,073,853 | — | 30 Sep 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.1%
|
669,615
|
$29,750,994 | — | 30 Sep 2024 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.1%
|
630,946
|
$28,033,000 | — | 30 Sep 2024 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1%
|
612,366
|
$27,208,000 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.99%
|
590,108
|
$26,218,499 | — | 30 Sep 2024 | |
| Caligan Partners LP |
13F
|
Company |
0.98%
|
579,717
|
$25,756,826 | — | 30 Sep 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.9%
|
532,404
|
$23,654,709 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.8%
|
476,657
|
$21,177,870 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.78%
|
465,620
|
$20,687,497 | — | 30 Sep 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.67%
|
400,849
|
$18,275,194 | — | 30 Sep 2024 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.66%
|
391,842
|
$17,409,540 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.59%
|
348,973
|
$15,504,873 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.56%
|
333,075
|
$14,798,522 | — | 30 Sep 2024 | |
| Eagle Health Investments LP |
13F
|
Company |
0.56%
|
330,830
|
$14,698,777 | — | 30 Sep 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.48%
|
285,099
|
$12,666,949 | — | 30 Sep 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.44%
|
261,505
|
$11,618,147 | — | 30 Sep 2024 | |
| AXA S.A. |
13F
|
Company |
0.4%
|
238,750
|
$10,607,663 | — | 30 Sep 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.39%
|
233,056
|
$10,354,678 | — | 30 Sep 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.38%
|
227,272
|
$10,365,876 | — | 30 Sep 2024 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.36%
|
212,976
|
$9,705,316 | — | 30 Sep 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
196,399
|
$8,726,008 | — | 30 Sep 2024 | |
| Cutter Capital Management, LP |
13F
|
Company |
0.31%
|
186,623
|
$8,291,660 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.3%
|
180,417
|
$8,015,927 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.3%
|
178,425
|
$7,927,421 | — | 30 Sep 2024 | |
| NORGES BANK |
13F
|
Company |
0.3%
|
175,855
|
$7,813,238 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.27%
|
162,741
|
$7,230,582 | — | 30 Sep 2024 | |
| CenterBook Partners LP |
13F
|
Company |
0.26%
|
154,088
|
$6,846,130 | — | 30 Sep 2024 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.25%
|
150,785
|
$6,699,378 | — | 30 Sep 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.24%
|
144,020
|
$6,398,809 | — | 30 Sep 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.24%
|
143,431
|
$6,372,639 | — | 30 Sep 2024 |
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO) as of Q4 2024
As of 31 Dec 2024,
AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO) was held by
221 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,832,436 shares.
The largest 10 holders included
FARALLON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock, Inc., Bellevue Group AG, PRICE T ROWE ASSOCIATES INC /MD/, ARMISTICE CAPITAL, LLC, STATE STREET CORP, Erste Asset Management GmbH, MACQUARIE GROUP LTD, and Jefferies Financial Group Inc..
This page lists
221
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
204
Q4 2024 holders
221
Holder diff
17
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.